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DURING the war the pharmacology of the nitrogen mustards or chloroethyl-
amines was studied intensively (Gilman and Philips, 1946). In the course of
these investigations it was observed that tissues with a high proportion of
dividing cells were particularly injured. This discovery led to the application
of these substances in the treatment of malignant growth. The nitrogen mus-
tards were injected into human patients suffering from cancers or leukaemia
(Goodman, Wintrobe, Dameshek, Goodman, Gilman and McLennan, 1946;
Wilkinson and Fletcher, 1947; Jacobsen, Spurr, Burton, Smith, Lushbaugh and
Dick, 1946). There is no doubt that the procedure wasjustified, as manypatients
suffering from Hodgkin's disease must by now have benefited by treatment with
these drugs (Rhoads, 1946). Experiments on tumour-bearing animals and trials
on patients with bronchogenic carcinoma, using the following chloroethylamines
are described.
(1) Methyl-bis-(P-chloroethyl)amine hydrochloride (HN2).
(2) tris(p-chloroethyl)amine hydrochloride (HN3).
(3) Dimethyl-,B-chloroethylamine hydrochloride.
METHOD OF ACTION.
The vesicants, mustard gas and the nitrogen mustards, are toxic substances
producing biological effects similar to those produc3d by ionizing radiations.
Data available would suggest that a dose of 0.1 mg. per kg. of methyl-bis-
(3-chloroethyl)amine is equivalent to a total body irradiation with about 50 r.
The effects common to bis-(,3-chloroethyl)amines and radiations include:
(a) Nausea and vomiting after moderate dosages.
(b) Haemoconcentration and death after 3 to 14 days following large doses.
(c) Thrombocytopenia leading to petechiae and extensive haemorrhages.
(d) Leucopenia.
(e) "Greying of hair.
(f) Vesication.
(g) Disturbance of mitosis with " stickiness " and fragmentation of chromo-
somes, resulting in cell degeneration.
(h) Production of mutations in Drosophila, Neurospora and bacteria.
Treatment with polychloroethylamines (HN2 and HN3) forms a possible
alternative to X rays for some diseases, particularly Hodgkin's disease. The
* Canadian Nufflield Dominion Travelling Fellow.
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effects seen in cases of bronchogenic carcinoma suggest that if the action of
chloroethylamines could be increased (a) by modification of the molecule, (b) by
improvement of the dosing schedule, or (c) by additional treatment with sub-
stances which might reduce the adverse effects, then useful results of definite
clinical value might be obtained.
Treatment with chloroethylamines makes it possible to produce effects in
tumours which are disseminated or localized in deep-seated tissues where radiation
therapy is difficult. There have been indications that cases ofHodgkin's disease
which have become resistant to X rays have responded to treatment with chloro-
ethylamines.
ANIMAL EXPERIMENTS.
The animal experiments have indicated the importance of adequate dosage
with substances ofthis type. IfC3H mice with spontaneous mammary tumours
or grafted lymphosarcomata, or rats with the Walker carcinoma, are given
daily doses of 01- mg. per kg. of methyl-bi8(f-chloroethyl)amine hydrochloride
(HN2) by subcutaneous or intraperitoneal injection, negligible inhibition of
tumour growth is obtained. With higher doses of the order of 1 mg. per kg.
complete inhibition of the growth of the Walker rat carcinoma was obtained,
and inhibition of spontaneous mammary tumours in mice occurred when doses
of 0 4 mg. per kg. were given. kSome experiments shown in Fig. 1 and 2
illustrate the increased effect ofsingle massive doses over divided doses.
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FIG. 1.-Survival times in days of C3H mice after grafting of the lymphosarcoma LSC.
The first group of mice received no treatment, while the other groups were injected with
methyl-bi8-(P.chloroethyl)amine, HN2 with different schedules of dosing.
When the mice were given daily doses of tris(r-chloroethyl)amine hydro-
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FIG. 2.-The growth of spontaneous mammary tumours in mice given intraperitoneal doses
of tri8(3-chloroethyl)amine (HN3). The treatment was most effective when given in
single large doses.
growth, but when later the same total amount was given in a single dose, in-
hibition of tumour growth occurred. Such inhibition was of temporary nature,
lasting about one week in the case of the Walker rat carcinoma and up to two
weeks in mice bearing spontaneous tumours. The effects of HN2, HN3 and
dimethyl-,3-chloroethylamine on spontaneous tumours are summarized in Table I.
Rats bearing the Walker carcinoma have been given weekly subcutaneous in-
jections of HN2-starting with 1 mg. per kg. for the first three weeks, and then
reducing the dose to 0.5 mg./kg. at weekly intervals. A proportion (4/10) of
rats treated in this way have been kept alive for three months, when all the
control animals died within 21 days of grafting the tumour.
A spontaneous lymphosarcoma (L.S.C.) was also used. This tumour on
transplantation into C3H mice usually kills the animals within 21 days, not by
means of growth of the local tumour, but with extensive invasion of tissues.
Treatment with small doses ofHN2 had very little effect on survival ofthe mice.
If treatment with weekly injections of 1 mg. per kg. HN2 was given commencing
10 days after implantation, the mice lived for from 18 to 35 days (Fig. 1).
Mice with spontaneous mammary tumours and mice with the grafted lympho-
sarcoma (L.S.C.) were treated with doses of 100 mg./kg. of dimethyl-,-chloro-
ethylamine hydrochloride by subcutaneous injection. Such treatment when
given repeatedly caused inhibition of some spontaneous mammary tumours
(Table I), but had very little effect in prolongingthe life ofmice with transplanted
lymphosarcoma. This compound given in single doses of 100 mg. per kg. to
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Neurotoxic effects were never seen with mice dosed with HN2 or HN3 in doses
up to 1 mg. per kg., although larger doses of both substances which have been
hydrolysed in neutral solution will cause rapid death with convulsions (Boyland,
1946).
An interesting effect noticed in mice was the bleaching of hair at the site of
injection (Fig. 3). It seems that subcutaneous injection ofHN2 inhibits pigment
formation in the skin of black or brown mice at the site of injection without
having any effect on the growth of hair. The effect is similar to that induced
by radioactive substances ; it is identical with the phenomenon ofdepigmentation
in mice caused by subcutaneous implantation ofplutonium (Brues, 19,47, personal
communication). Thus " bleaching of hair-colour " is another example ofthe
radiomimetic actions of the bis-chloroethylamines.
The metabolism of Walker carcinoma tissue from rats dosed with 1 mg. per
kg. HN2 was studied using the Warburg technique. A reduced glycolysis was
found for six days following a single treatment (Fig. 7), with no change in the
tumour respiration. The nature of the inhibition of glycolysis has not been
examined further, but it is probably due to inhibition of hexokinase or other
phosphate-transferring enzymes concerned in glycolysis. Dixon and Needham
(1946) found that vesicants-either mustard gas or chloroethylamines-inhibited
hexokinase when present in low concentrations, and suggested that vesication
was due to this inhibition. The inhibition of mitosis is possibly connected with
poisoning of enzymes of the same type either concerned in general metabolism,
or possibly in the changes in the nucleic acids or enzymes concerned in phosphate
transfer in nucleic acids ofthe chromosomes.
CYTOLOGICAL EFFECTS.
The cytological effects induced by chloroethylamines were studied in trans-
planted Walker rat carcinoma. The animals were injected intraperitoneally
with 1 mg. per kg. body weight 4-10 days after tumour implantation, and killed
at intervals offrom 6 hours to 5 days after treatment.
The earliest abnormalities were seen 8 hours after injection. These
included the formation of dumb-bell-shaped nuclei (Fig. 5), due to the fact that
at telophase the daughter chromosomes could not separate and move to the
opposite poles freely, owing to apparent stickiness of the chromosome ends
(Fig. 4). Eighteen hours after injection chromosomes individing cells fragmented
and mitosis remained incomplete (Fig. 6). This effect was most pronounced at
24 hours to 48 hours after treatment, when all dividing cells were abnormal and
cell proliferation might be stopped completely. This inhibition lasted for 3-7
days, after which time normal cell division was resumed. When the dose was
divided into two equal fractions and injected at 24-hour intervals, the cyto-
logical abnormalities were of the same kind as described above, but the damage
in individual cells was less severe. Loss of chromosome segments from the
nucleus leads to the death of the cell, and is also responsible for the arrest of
tumour growth. Treatment of rats with Walker carcinoma with doses of 100
mg./kg. ofdimethyl-3-chloroethylamine produced no abnormalities in the dividing
cells ofthe tumour tissue examined 24 and 48 hours after treatment.
The biological effects of nitrogen mustards induced in experimental animals
provide a rationale for employing them as chemotherapeutic agents in the treat-
ment of tumours.





FIG. 7.-The glycolysis of Walker rat carcinoma tissue at different times following treatment
of the rats with 1 mg. per kg. methyl-bi8(3-chloroethyl)amine (HN2).
EFFECTS ON BRONCHOGENIC CARCINOMA.
During the past three and a halfyears some 60 cases ofbronchogenic carcinoma
unsuitable for other forms oftherapy have been treated with various compounds.
From 1944 to 1946, 22 patients received either urethane, stilboestrol, dienoestrol,
dimethylaminostilbene or 4:4'-diaminodiphenylether. Symptomatic improve-
ment was observed in 1 of the 15 patients receiving urethane, but none of the
other drugs had any beneficial effect.
Rhoads (1946) reported a favourable but temporary effect in a case of ana-
plastic bronchogenic carcinoma receiving methyl-bis-(3-chloroethyl)amine, and
suggested that further clinical trials were justified. During the first 10 months
of 1947, 41 histologically proven cases of bronchogenic carcinoma have been
given this compound. Of this group 15 have been referred from the Brompton
Neoplastic Clinic, nine from the Royal Cancer Hospital (Free), and the remainder
from physicians in other London hospitals.
EXPLANATION OF PLATE.
FIG. 3.-Black mouse following three subcutaneous injections each of 0 004 mg. of methyl-
bi8(,3-chloroethyl)amine (HN2), showing bleaching or " greying " of hair. Photograph
taken six months after the last injection.
FIG. 4.-Cell of Walker rat carcinoma in mitosis 12 hours after injection of HN2. The
nucleic acid charge of the chromosomes is altered, causing stickiness of chromosomes.
X 1650.
FIG. 5.-Two cells of Walker rat carcinoma with dumb:bell-shaped nuclei, 24 hours after
HN2. The daughter chromosomes did not separate, and the two daughter nuclei remain
in association. x 1650.
FIG. 6.-Cell of Walker rat carcinoma in anaphase of mitosis 48 hours after HN2. Several
of the chromosomes are fragmented, the fragments are left scattered in the cytoplasm and
will be lost from the nuclei. x 1550.BRITISH JOURNAL OF CANCER.
Boyland, Clegg, Koller, Rhoden and Warwick.
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Unsuitability for surgery implies that the growth is not resectable, and for
radiation therapy that the patient is too ill for such treatment, that there is
evidence of extension of the disease beyond the mediastinum, or that there is
fever or pleural exudation. The prognosis in cases unsuitable for surgery and
radiation therapy is indicated by the fact that of an untreated group of 50
clinically similar cases, one-third died within 1 month and none lived beyond 8.
In this group, one-third were dangerously ill, being bed-ridden with the
disease. The sex incidence and frequency distribution of histological type were
similar to those of a total group of 194 seen at the Brompton Neoplastic Clinic.
Thirty-three patients had no previous treatment. Of the remainder, 3 had
exploratory thoracotomy, 1 had pneumonectomy with later appearance of
secondaries, and 4 had received radiation therapy which had been either clinically
unsuccessful, or had been followed in a few months' time by recurrence of symp-
toms and progression of the disease.
Form of treatment.
All patients in this group except 1 received methyl-bis-(3-chloroethyl)amine
hydrochloride (HN2). A variant of this compound, dimethyl-]3-chloroethyl-
amine hydrochloride, was used in 3 other cases, reported here because of the
favourable response in 1 case. The compound HN2 was given intravenously
in a dose of 0-2 mg. per kg. on two consecutive days in 30 cases, in 10 of which
treatment was repeated once or several times at 3-week or longer intervals
depending upon the length ofremission from symptoms. Two patients received
1 single injection of 0-2 mg. per kg., and two received 1 injection of 0 4 mg. per
kg. Four patients received injections of 0-2 mg. per kg. at weekly or 10-day
intervals for periods of up to 10 weeks. In the cases receiving the dimethyl
compound, 3 mg. per kg. was given the first day and a dose of 5 mg. per kg.
the following day.
Several ofthe ambulant cases received treatment as out-patients, and it would
seem that there is no contraindication to such treatment, provided the patient
can be returned to his home within an hour ofthe injection.
Adverse effects of treatment.
No serious reactions have been observed in this group. In almost all patients
Table II) nausea and vomiting follow injection one to two hours later and
TABLE II.-Adverse Effects ofHN2.
Total number ofinjections . 152
Nausea . . . . 130
Vomiting . . . . 121
Anorexia . . . . 94
Weakness . . . . 15
'Drowsiness . . . 13
Light-headedness . . 7
Thrombophlebitis . . 4
Diarrhoea . . . . 2
Rigor . . . . 2
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continue in most cases for 3-4 hours. In the majority anorexia persists for 24
hours. Feelings of weakness, drowsiness and lightheadedness may occur. In
1 patient such symptoms persisted for 1 week. Thrombophlebitis at the site
of the injection, of no serious consequence, followed 4 of over 150 injections.
Diarrhoea was remarked upon by 2 patients, and lasted for 3 and 24 hours res-
pectively. Rigors lasting a few minutes have followed 2 injections.
WV,ith a dosage of 0-2 mg. per kg. on consecutive days the effects on the white
cell count have not been serious. The majority of patients with advanced
bronchogenic carcinoma have white cell counts above 10,000 per c.mm., and
such patients do not develop the moderate to severe leucopenia observed in cases
ofHodgkin's disease (ApThomas andCullumbine, 1947). In only 2ofour patients
has the white cell count fallen below 4000 per c.mm., in these cases to 1000
and 1800 with restoration to normal counts in 3 weeks' time. The first of these
cases hadhadprevious radiation therapy, and at the commencement oftreatment
had awhite blood cell count of4000 per c.mm. Haemorrhagicnianifestations have
not been observed in this group, nor has any significant change in haemoglobin
been noted. Dosages of 0-2 mg. per kg. at 10-day intervals can be tolerated for
periods of at least 10 weeks, as judged by the 4 cases we have treated over such
a period. The presence of fever, pleural exudation or jaundice are not, in our
experience, contraindications to the use ofthe drug.
The adverse effects of the dimethyl compound were observed in 3 patients,
2 of whom are not included in this group as their diagnosis was not histologically
proven. Each of these patients had flushing at the time of injection. Nausea
and vomiting were similar to that following the use of HN2, but neurological
effects were seen. Patients stated that for several days they could not taste
their food; one was confused and disoriented for 5 days, and another, besides
being disoriented, was irrational and had incontinence of urine.
Effects of treatment.
Twenty-five of the cases reported in this group are still living and have been
under observation from 4 to 10 months. Sixteen patients have died.
In estimating the effects of treatment this group may be divided into four
classes:
(1) Showing symptomatic relief with objective signs of improvement (18).
(2) Showing symptomatic relief only (6).
(3) Showing objective signs of improvement with no symptomatic relief (1).
(4) Showing no apparent effect (16).
Remissions when they occur usually last 2 to 12 weeks. Further injections
produced similar results in most cases. One patient was carried on for a period
of 5 months with marked relief ofpain, cough and dyspnoea and decrease of
sputum for 18 to 21 days following each course of injections. He then showed
no further response to the drug and died soon thereafter. A patient with re-
mission of symptoms for 6 to 8 weeks after each treatment is still being observed
after 9 months. One patient receiving dimethyl-,3-chloroethylamine is still in
remission 7 months aftertreatment andleadinganormallife. Two otherpatients,
however, not histologically proven, and therefore not included in this report,
were also given the same drug with no apparent beneficial effect.
It is noteworthy that over halfofthe patients have had relieffrom their most
distressing symptom. The effect on pain (Table TII) is remarkable in someEFFECTS OF CHLOROETHYLAMINES ON TUMOURS
TABLE III.-Symptomatic Relieffollowing HN2.
Total number of cases, . . 41
Symptomatic relief . . . . 24
Number of Relief
cases. obtained.
Pain . . . . 23 . 17
Cough . . . . 25 . 16
General malaise . . 27 . 16
Anorexia . . . 23 . 14
Dyspnoea . . . 22 . 11
Hoarseness . . . 8 . 0
cases, relief being experienced within 8 to 48 hours. The pain referred to as
being " deep in the chest " is the type most commonly relieved, in contrast to
the more localized pain of pleural origin.
Cough is often decreased in severity and may cease altogether. The relief of
dyspnoea in some cases is almost complete-an observation very difficult to ex-
plain, for in such cases there may not be corresponding observable changes in the
lungs.
Relief of general malaise and anorexia is also noted in over half the cases
following the initial 1-or 2-day period ofadverse effects. Improvement in hoarse-
ness, secondary to involvement of the recurrent laryngeal nerves, did not occur
in any of the cases.
Objective signs of improvemient.
Approximately one-half of the patients (Table IV) had some measurable
beneficial effect of treatment, and in all except one of these some symptomatic
relief was also experienced.
TABLE IV.-Objective Improvementfollowing HN2.
Total number of cases . . . . . 41
Objective signs ofimprovement . . . . 19
Number of Effects
cases. noted.
Decrease, caval obstruction . . . 5 . 3
Decrease, sputum . . . . 30 . 18
Decrease, pleural exudate . . . 13 . 5
Decrease, metastatic tumour size . . 10 . 4
Increase, weight . . . . 22 . 9
Radiological improvement . . . 35 . 8
Remission, physical signs (chest) . . 39 . 9
Remission, neurological signs . . 10 . 1
Of 5 patients with obstruction of the superior vena cava, swelling of the arms
disappeared in 1. In 2 others who were moribund at time oftreatment regression
of swelling to one-half the original size was noted within a week of treatment.
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Sputum usually increases in amount for several days, and is said " to come
up more easily." The amount may then fall off rapidly, in some cases from
90-120 ml. to 15 ml. or nil within a week. The sputum may also change in
character from purulent to colourless.
Reabsorption of pleural exudate or decreased rate of formation has been
seen in 5 of 13 cases. These observations are of interest in that most radio-
'therapists hesitate to give treatment to cases with pleural exudation because of
the tendency to increase the amount of exudate.
Superficial metastases of measurable size decreased in 3 of 10 cases. A
larger total number for such observations wouild have been obtained had not
metastatic nodules been removed for microscopic study at various intervals
following injection in 8 cases.
Twenty-two patients who had weight loss were weighed weekly following
treatment. In 9 of these cases weight loss continued for approximately 1 week,
following which a gain in weight occurred amounting uisually to 2 to 8 lb.
Four patients gained 10 to 15 lb. in 2 months, and 1 patient who lost 40 lb.
in the 18 months prior to treatment with dimethyl-3-chloroethylamine has in 7
months regained all her lost weight.
Radiological evidence of decrease in size of pulmonary metastases and
re-aeration ofsegments or lobes was observed in 8 of 35 cases. Such changes may
happen within 5 to 7 days.
A favourable change in physical signs ofthe chest was noted in 9 of 39 cases,
and included those cases with re-aeration ofparts ofthe lung or decrease in pleural
exudate.
As already mentioned, recovery of function from paralysis of the recurrent
laryngeal nerves has not been noted. In one patient, however, with involvement
of the twelfth cranial nerve, complete recovery of function occurred in 9 days
and lasted for 7 weeks. Unfortunately, repetition of treatment was not possible
in this case.
The appearance of primary tumours at bronchoscopy several days to several
weeks following treatment has in the 6 cases observed been unaltered in 3 com-
pared with previous examination. In 3 other cases the tumour area was said
to be clearer and to bleed less readily, although a change in sizewas not observed.
Histological examination of primary or metastatic growth prior to and at
various intervals following treatment was carried out in 8 cases. In all post-
treatment specimens a great deal of necrosis was present, but one cannot say that
such appearances are the result of therapy, for necrosis was seen in many of the
pre-treatment specimens as well. Fragmentation ofthe chromosomes ofdividing
cells as described by Koller (1947) was not observed in 2 ofthe 8 specimens.
Case reports.
Case 1.-J. H-, male, aged 65. Seen first at neoplastic clinic December 13,
1946.
Symptoms: Cough, sputum, general malaise. Anorexia and dyspnoea on
exertion for 4 months. Loss of weight-33 lb. in one year. Poor general
condition; signs of consolidation and atelectasis right lower lobe. Small firm
gland in right supraclavicular fossa. Weight 111 lb. Sputum, 90 ml. per day
muco-purulent. X ray chest December 13, 1946, showed collapse and consoli-
dation right lower lobe.EFFECTS OF COLOROETHYLAMINES ON TUMOURS
Bronchoscopy December 19, 1946. Ulcerated stricture of the right lower
bronchus at the level of the middle bronchus almost obliterating the lumen.
In view of the patient's age, poor general condition and the presence of small
firm gland in the right supraclavicular fossa, operation contraindicated.
Pathological report: Poorly differentiated squamous carcinoma.
The presence of a supraclavicular gland made this patient unsuitable for
X ray therapy and he was referred for chemotherapy. Two doses of methyl- bis-
(chloroethyl)amine (0-2 mg. per kg.) given on two consecutive days were followed
by nausea and vomiting after each injection. Immediately after the first in-
jection the patient had a rigor for 5 minutes. Temperature 1010. Forty-
eight hours after second injection the cough decreased, dyspnoea was much
improved and the sputum decreased to 15 ml. per day. Appetite improved,
and following initial loss of weight of 3 lb. he gained 8 lb. in one month.
The cough and sputum started to increase again in 8 weeks' time but dyspnoea
did not return. Radiological examination revealed no changes in the lungs
following therapy. Treatment has been repeated on two occasions since with cor-
responding remission of symptoms and decrease of sputum. Present weight is
108 lb. and general condition remains about the same as when first seen, there
being no clinical or radiological evidence of progression of the disease.
Case 2.-L. P-, female, aged 47. Admitted to the Royal Cancer Hospital for
treatment by Mr. R. W. Raven, April 24, 1947.
Symptoms: Cough with sputum. pain in the chest and dyspnoea 16 months.
Loss of weight-40 lb. in 16 months. Patient moribund and emaciated, lying
curled in bed without any interest in surroundings. Signs of collapse of right
lung with mediastinal shift. Pulse 100. Respirations 24 per minute. Weight
81 lb. Sputum 30 ml. purulent and foul-smelling. Hb, 55 per cent. R.B.C.,
3,800,000. W.B.C., 12,600.
X ray of chest April 8, 1947. Heart, mediastinum and trachea displaced
to the right; appearance of atelectasis with probable cavitation near 2nd right
rib. Bronchoscopy report from Harefield in April, 1946. Carina broadened
and invaded on the right by a large nodular friable mass completely occluding
the right main bronchus.
Pathological report: Adenocarcinoma with numerous mitotic figures.
Treatment: Dimethyl-chloroethylamine 2 mg. per kg. first day and 5 mg.
per kg. second day. Flushing was noticed immediately after each injection.
Nausea and vomiting were slight, and therewas a feeling ofnumbness and "large-
ness " of the tongue with loss of taste for four days. Within one week pain and
cough had disappeared. Dyspnoea at rest disappeared in two weeks. The
sputum at first increased in amount and lost its bad taste, then decreased, with
the cough finally disappearing. General condition slowly improved and in
three months the patient was up. Weight steadily increased until 40 lb. was
gained. Haemoglobin rose to 87 per cent. The only symptoms at present are
a slight cough with a little colourless sputum and dyspnoea on exertion. The
X ray appearances are unchanged, but the patient is leading a normal life and
looking after her own home.
DISCUSSION.
The findings are of some theoretical interest in that a demonstrable clinical
effect of the chloroethylamines on bronchogenic carcinoma in man has been
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established. Other workers have been unable so far to demonstrate a corre-
sponding effect on other types of carcinoma in human patients. This probably
indicates some tissue specificity of action. It must be remembered, however,
that patients are acutely conscious of symptoms referable to the chest and of
their degree of severity. It may be that in bronchogenic carcinoma a slight
diminution in size of a tumour or amount ofti3sue reaction around it is sufficient
to afford considerable relief from the distressing symptoms. A corresponding
effect in a tumour of the breast might reasonably be expected not to be noticed
by the patient. In support of such a suggestion is the fact that a similar relief
ofrespiratory symptoms following chloroethylamine without radiological evidence
of changes in the lungs has been observed in a case of carcinoma of the breast
with pulmonary metastases. On the other hand, metastatic nodules of broncho-
genic carcinoma have been seen to decrease in size or even disappear, whereas
such changes have not been observed with other types of carcinoma similarly
treated at the Royal Cancer Hospital.
From a therapeutic standpoint it can be stated that little has been added to
the satisfactory handling of cases of carcinoma of the lung. Impressions based
on this study are that the use ofthe drug may be ofsome value in cases unsuitable
for other forms of therapy, where relief of distressing symptoms may make the
patient's remaining days more tolerable. Such advantages, however, should be
weighed against the probable amount of discomfort which will be caused by
treatment.
There is no definite evidence that the drug alters the progressive course of
the disease in the selected group ofpatients studied, although in the case histories
presented it would seem that treatment had a very favourable result, which
would not have been expected to occur by chance alone.
The results of further investigations with different dosages ofthese drugs and
variations in the schedule of administration, of the effects in a group of less
advanced cases and in a series at present being treated by combination of the
drug with radiation therapy, should establish whether these compounds are of
more than temporary palliative value. If a palliative remedy is employed then
it should be employed continuously at the optimum level ofdosage. This dosage
remains to be determined.
SUMMARY.
Methyl-bis(p-chloroethyl)amine hydrochloride (HN2) and tris(p-chloroethyl)-
amine (HN3) produce many effects similar to those caused by X rays, including
the greying ofhair ofmice at the site ofinjections.
Injection of HN2 or HN3 in adequate doses into animals with particular
tumours causes temporary inhibition of tumour growth. This inhibition is
accompanied by a reduction in tissue glycolysis. These substances have nucleo-
toxic actions, as shown by apparent increased stickiness and fragmentation of
chromosomes which lead to the death of the injured cell. By repeating the
treatment at suitable intervals the life ofanimals with tumours can be prolonged,
but cessation of treatment leads to recurrence of tumour growth.
Forty-one cases of histologically proven carcinoma of the bronchus unsuitable
for other forms of therapy have been treated with the chloroethylamines. No
serious adverse reactions have been noted. Symptomatic relief and objective
signs of improvement were noted in approximately one-half of the cases.CULTURE OF LEUKAEMIC BLOOD CELLS 29
Remissions, when occurring, have lasted usually from two weeks to three
months. The theoretical interest of the apparent specificity of chloroethyl-
amine in bronchogenic carcinoma and the indications for its possible use as a
palliative measure in advanced cases of the disease are discussed.
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THE aim ofthe work reported in this paper was to perfect a simple and reliable
technique for the culture ofhuman leukaemic blood cells, and with it to construct
a quantitative base line which would later be available for testing the effects in
vitro of therapeutic measures such as ionizing radiations or chemical agents.
These effects express themselves as changes in the number as well as the appear-
ance of various cell types. Furthermore, the effect on cells in mitosis is of
particular interest and importance.
The results which are here reported provide the necessary controls for experi-
ments with therapeutic agents, by establishing the rate of growth and decay
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